Literature DB >> 11770104

The heat shock protein 90 of Leishmania donovani.

M Wiesgigl1, J Clos.   

Abstract

The 90-kDa heat shock protein (Hsp90) of Leishmania donovani is a highly abundant cytoplasmic protein and is involved in a variety of cellular processes. Pharmacological deactivation of Hsp90 leads to growth arrest and induces the synthesis of heat shock proteins. Moreover, treatment of promastigote parasites with Hsp90 inhibitors induces the synthesis of amastigote-specific marker proteins and a morphological alteration similar to axenic amastigote differentiation. We propose a role for Hsp90 in the feedback control of the cellular stress response and in the control of the parasite's life cycle.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11770104     DOI: 10.1007/s004300100074

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  13 in total

1.  The Hsp70/J-protein machinery of the African trypanosome, Trypanosoma brucei.

Authors:  Stephen John Bentley; Miebaka Jamabo; Aileen Boshoff
Journal:  Cell Stress Chaperones       Date:  2018-12-01       Impact factor: 3.667

2.  Inhibition of HSP90 in Trypanosoma cruzi induces a stress response but no stage differentiation.

Authors:  Sebastian E B Graefe; Martina Wiesgigl; Iris Gaworski; Andrea Macdonald; Joachim Clos
Journal:  Eukaryot Cell       Date:  2002-12

Review 3.  Heat Shock Proteins as the Druggable Targets in Leishmaniasis: Promises and Perils.

Authors:  Pragya Prasanna; Arun Upadhyay
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

4.  Proof of interaction between Leishmania SIR2RP1 deacetylase and chaperone HSP83.

Authors:  Monte-Alegre Adriano; Baptiste Vergnes; Joel Poncet; Françoise Mathieu-Daude; Anabela Cordeiro da Silva; Ali Ouaissi; Denis Sereno
Journal:  Parasitol Res       Date:  2006-11-10       Impact factor: 2.289

5.  Apoptosis caused by Hsp90 inhibitor geldanamycin in Leishmania donovani during promastigote-to-amastigote transformation stage.

Authors:  Qiaoli Li; Ying Zhou; Chenjiang Yao; Xiaoping Ma; Lianyun Wang; Wangjie Xu; Zhaoxia Wang; Zhongdong Qiao
Journal:  Parasitol Res       Date:  2009-08-19       Impact factor: 2.289

6.  Anti-malarial activity of geldanamycin derivatives in mice infected with Plasmodium yoelii.

Authors:  Rubul Mout; Zhi-Dong Xu; Angela K H Wolf; Vincent Jo Davisson; Gotam K Jarori
Journal:  Malar J       Date:  2012-02-23       Impact factor: 2.979

7.  Chemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.

Authors:  Diego M Santos; Antonio L O A Petersen; Fabiana S Celes; Valeria M Borges; Patricia S T Veras; Camila I de Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

8.  Increased Abundance of Proteins Involved in Resistance to Oxidative and Nitrosative Stress at the Last Stages of Growth and Development of Leishmania amazonensis Promastigotes Revealed by Proteome Analysis.

Authors:  Pedro J Alcolea; Ana Alonso; Francisco García-Tabares; María C Mena; Sergio Ciordia; Vicente Larraga
Journal:  PLoS One       Date:  2016-10-24       Impact factor: 3.240

9.  Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design.

Authors:  Juan Carlos Pizarro; Tanya Hills; Guillermo Senisterra; Amy K Wernimont; Claire Mackenzie; Neil R Norcross; Michael A J Ferguson; Paul G Wyatt; Ian H Gilbert; Raymond Hui
Journal:  PLoS Negl Trop Dis       Date:  2013-10-17

10.  Immunolocalization of anti-hsf1 to the acetabular glands of infectious schistosomes suggests a non-transcriptional function for this transcriptional activator.

Authors:  Kenji Ishida; Melissa Varrecchia; Giselle M Knudsen; Emmitt R Jolly
Journal:  PLoS Negl Trop Dis       Date:  2014-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.